Strategic Financial Concepts LLC Buys New Shares in DaVita Inc. (NYSE:DVA)

Strategic Financial Concepts LLC bought a new stake in DaVita Inc. (NYSE:DVA - Free Report) in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor bought 62,661 shares of the company's stock, valued at approximately $9,371,000. Strategic Financial Concepts LLC owned about 0.08% of DaVita as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently modified their holdings of DVA. JPMorgan Chase & Co. raised its holdings in DaVita by 17.8% in the 3rd quarter. JPMorgan Chase & Co. now owns 609,076 shares of the company's stock valued at $99,846,000 after acquiring an additional 92,014 shares during the last quarter. KBC Group NV increased its holdings in shares of DaVita by 0.8% in the fourth quarter. KBC Group NV now owns 316,155 shares of the company's stock valued at $47,281,000 after purchasing an additional 2,636 shares during the last quarter. BNP Paribas Financial Markets lifted its position in DaVita by 23.9% during the third quarter. BNP Paribas Financial Markets now owns 292,039 shares of the company's stock worth $47,874,000 after buying an additional 56,389 shares in the last quarter. Nordea Investment Management AB boosted its stake in DaVita by 4.9% during the fourth quarter. Nordea Investment Management AB now owns 264,535 shares of the company's stock worth $39,712,000 after buying an additional 12,339 shares during the last quarter. Finally, abrdn plc grew its holdings in DaVita by 1.2% in the 3rd quarter. abrdn plc now owns 189,065 shares of the company's stock valued at $30,719,000 after buying an additional 2,180 shares in the last quarter. 90.12% of the stock is owned by hedge funds and other institutional investors.

DaVita Trading Down 0.1 %

DVA stock traded down $0.21 during midday trading on Wednesday, hitting $154.84. 1,235,190 shares of the company's stock were exchanged, compared to its average volume of 776,643. DaVita Inc. has a 1-year low of $119.42 and a 1-year high of $179.60. The company has a current ratio of 1.26, a quick ratio of 1.21 and a debt-to-equity ratio of 23.18. The stock has a market capitalization of $12.39 billion, a PE ratio of 14.42, a P/E/G ratio of 0.79 and a beta of 0.94. The business has a 50-day simple moving average of $161.40 and a two-hundred day simple moving average of $157.89.

DaVita (NYSE:DVA - Get Free Report) last issued its quarterly earnings data on Thursday, February 13th. The company reported $2.24 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.14 by $0.10. DaVita had a return on equity of 115.48% and a net margin of 7.31%. On average, sell-side analysts predict that DaVita Inc. will post 10.93 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Separately, Barclays boosted their price target on shares of DaVita from $164.00 to $169.00 and gave the company an "equal weight" rating in a research report on Tuesday. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and two have assigned a buy rating to the company. According to MarketBeat.com, the company presently has an average rating of "Hold" and an average target price of $162.80.

About DaVita

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.